Differences

This shows you the differences between two versions of the page.

--- alberta_innovates [2022/10/26 21:51]
liam [Subsidiaries]
+++ alberta_innovates [2024/07/17 17:46] (current)
liam [Subsidiaries]
@@ Line 5: / Line 5: @@
 **Alberta Innovates** is a Canadian provincial government agency owned and operated by the Province of [[canada:Alberta]].
+===== History =====
+In 2011, Alberta Innovates partnered with [[pharmaceutical_companies:Pfizer]], the [[Alberta Ministry of Economic Development and Trade]] and [[Western Economic Diversification Canada]] to create and co-manage the Alberta/Pfizer Translational Research Collaboration Fund. Later renamed to the Pfizer-Alberta Collaboration in Health, the fund totaled $3.5 million in 2013.
+In November 2018, Pfizer and the [[Government of Alberta]] announced an additional $1.3 million contribution to the fund. This brought the fund value at the time to over $4.8 million.((Brunner, D. (2018, November 26). //Alberta Government and Pfizer Canada boosts provincial collaborative health innovation partnership with Alberta Innovates.// Alberta Innovates. https://archive.ph/1ppaw))
+==== COVID-19 ====
+In September 2020, Alberta Innovates announced $2.1 million in funding for [[COVID-19]] research. Seven projects were selected for funding out of a pool of 28 applicants:((Semeniuk, R. (2020, September 10). //Alberta Innovates injects $2.1 M into COVID Research.// Alberta Innovates. https://web.archive.org/web/20221026201102/https://albertainnovates.ca/impact/newsroom/alberta-innovates-injects-2-1-million-into-covid-research/))
+^ Principal Investigator  ^ Organization  ^ Title  ^ Funding  ^
+| [[Jie Chen]]  | [[University of Alberta]]  | Development and Clinical Validation of a Rapid Antibody Detection Device for COVID-19  | $304,200  |
+| [[Andrei Drabovich]]  | University of Alberta  | Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays  | $182,098  |
+| [[Matthias Hoben]]  | University of Alberta  | COVID-19 and Caregivers of Assisted living Residents: their Experiences and Support needs (COVCARES-AB/BC)  | $328,376  |
+| [[Jia Hu]]  | [[University of Calgary]]  | Changing COVID-19 Behaviors through a data-driven targeted marketing campaign ([[19 to Zero]])  | $392,080  |
+| [[Mark Lewis]]  | University of Alberta  | Predicting and managing COVID-19 pandemic dynamics using machine learning  | $220,545 (supported through the Pfizer-Alberta Collaboration in Health)  |
+| [[Ken Parhar]]  | University of Calgary  | The Evaluation of a PRONe Positioning Knowledge Translation Toolkit in COVID-19 ARDS (PRONTO) study 	 | $362,285  |
+| [[Puneeta Tandon]]  | University of Alberta  | Reconnecting vulnerable outpatients with multidisciplinary care – an RCT assessing online programming in the time of COVID-19  | $326,297  |
 ===== Organization =====
 ==== Subsidiaries ====
-AI operates two subsidiary companies; [[C-FER Technologies]] and [[InnoTech Alberta]]. It also runs the [[Alberta Foundation for Health Research]].((//Alberta Foundation For Health Research.// Charitable Impact. Retrieved October 26, 2022, from https://my.charitableimpact.com/charities/alberta-foundation-for-health-research))
+AI operates two subsidiary companies; [[C-FER Technologies]] and [[InnoTech Alberta]]. It also runs the [[Alberta Foundation for Health Research]].((//Alberta Foundation For Health Research.// Charitable Impact. Retrieved October 26, 2022, from https://archive.ph/7dBQu))
+C-FER works in partnership with the global energy industry, while InnoTech works with environmental, biological, and energy technology companies.
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Alberta-Innovates|White Rose Wiki]]